CSF3 and Kaposi's sarcoma: Together with higher PDGF-AA-AB and GCSF plasma levels in HIV KS, these observations foster relevance for PD-1 inhibitors and antiangiogenic drugs currently being tested to optimize therapeutic interventions for KS [3].